Versanis Bio secured $70 to commercialise a treatment licensed from Novartis, while Salesforce, Intel, Orange, Nike and Alphabet all celebrated exits.

China Life has boosted the industrial internet-of-things specialist in its quest to deliver the advantages of industry 4.0.

The blood disease specialist secured a boost from Alexandria Real Estate Equities, Novo and Access Biotechnology to move two assets into phase 2 trials.

Humane aims to deliver “the next shift between humans and computing” with series B funding from investors including Qualcomm and SoftBank.

Alexandria Venture Investments is among the investors supporting the immunotherapy developer focused on cancer, autoimmune and infectious diseases.

Hearst, MassMutual and Nationwide have returned to invest in insurance comparison platform operator Insurify‘s series B round.

Koch Industries is among the investors backing the autonomous short-haul provider as hits more than $114m in total funding.

The Ethereum scaling technology developer raised two rounds this year as it prepares to move its platform out of beta.

Genomics care provider Genome Medical closed a $60m round backed by several corporates while brokerage software producer Alpaca secured $50m.

Opt's Bonds Investment Group led interior design sharing platform RoomClip's series E round in addition to online learning platform developer Schoo's series D.